Stock Updates

How has GlaxoSmithKline plc:(NYSE:GSK) performed recently?

GlaxoSmithKline plc (NYSE: GSK) is a large market cap stock with a market cap of 105036.08. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 132.43, a forward P/E of 16.92 and EPS of 0.33. At a stock price of 43.71 (-1.18%) it has a dividend yield of 5.02%.

EPS growth for the last five years have been 40.20%, more recently this last year it has grown by 204.10%. The next year growth is going to be about 14.35% and more long-term 0.60% after five years. EPS growth quarter over quarter is -96.60%. Sales growth for the past five years have been -3.40% and sales growth quarter over quarter is 10.80%.

For performance, GlaxoSmithKline plc the past week has seen a gain of 1.63%. For the last month performance for GlaxoSmithKline plc is 9.02%. While the last quarter is 3.82% and half year, 18.86%. Finally for the year, performance is 10.62%.

The 52-week high for GlaxoSmithKline plc, is at -1.35%, and for the 52-week low it comes to a value of 24.45%. The 20-day simple moving average is 3.34% and 9.20% for the 200-day simple moving average.

Volatility for the week is at 0.97%, and for the month it is 1.42%. GlaxoSmithKline plc, has a target price of 47.

In terms of debt, long term debt/equity is 5.61, and for total debt/equity GlaxoSmithKline plc has 6.05. The gross margin is 66.40%, while operating margin is 7.50%, the profit margin is 2.50%. The current ratio is 1.1 and the quick ratio is 0.8.

Insider ownership is at 0.20%, with instituitional ownership at 8.60%. GlaxoSmithKline plc has a payout ratio of 629.40%. With the total shares outstanding coming to 2374.77. The shares float is 2374.77, with the float short at 0.26%, with short ratio coming to 1.78.

In terms of returns, the return on assets see GlaxoSmithKline plc, get 1.10%, with its returns on investment at 41.40%. Return on equity is 12.20%. So will the investors see the target price of 47, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment